Cyanosis, hemolysis, decreased HbA1c and abnormal co-oximetry in a patient with hemoglobin M Saskatoon [HBB:c.190C > T p.His64Tyr]

References

• Giardine BM, Joly P, Pissard S, et al. Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2021 Jan 8;49(D1):D1192–D1196.
   Web of Science ®Google Scholar
• Hardison RC, Chui DH, Giardine B, et al. Hbvar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002 Mar;19(3):225–233.
   PubMed Web of Science ®Google Scholar
• Harteveld CL. State of the art and new developments in molecular diagnostics for hemoglobinopathies in multiethnic societies. Int J Lab Hematol. 2014 Feb;36(1):1–12.
   PubMed Web of Science ®Google Scholar
• Baltzan DM, Sugarman H. Hereditary cyanosis. Can Med Assoc J. 1950 Apr;62(4):348–350.
   PubMed Web of Science ®Google Scholar
• Baine RM, Wright JM, Johnson MH, et al. Biosynthetic evidence for instability of HB M Saskatoon. Hemoglobin. 1980;4(2):201–207.
   PubMed Web of Science ®Google Scholar
• García-Morin M, Manrique-Martin G, Ropero P, et al. Hb M-Saskatoon: an unusual cause of cyanosis in a Spanish child. Pediatric Hematology Oncology Journal. 2019;4(1):23–26.
   Google Scholar
• Shibata S, Miyaji T, Iuchi I, et al. Hemoglobin M-Kurume: its identity with hemoglobin M-Saskatoon. Nippon Ketsueki Gakkai Zasshi. 1962 Oct;25:690–694.
   PubMedGoogle Scholar
• Pik C, Raine DN. The chemical identification of two cases of Hb M (Hb M Boston and Hb M Saskatoon) occurring in England. Clin Chim Acta. 1964 Jul;10:90–92.
   PubMed Web of Science ®Google Scholar
• Betke K, Kleihauer E, Gehring-Muller R, et al. [HbM Hamburg, a beta chain anomaly: alpha-2-beta-2-63Tyr (equals HbM Saskatoon)]. Klin Wochenschr. 1966 Aug 15;44(16):961–966.
   PubMedGoogle Scholar
• Hayashi A, Shimizu A, Yamamura Y, et al. Hemoglobins M: identification of Iwate, Boston, and Saskatoon variants. Science. 1966 Apr 8;152(3719):207–208.
   PubMed Web of Science ®Google Scholar
• Efremov GD, Huisman TH, Stanulovic M, et al. Haemoglobin M Saskatoon and haemoglobin M Hyde Park in two Yugoslavian families. Scand J Haematol. 1974;13(1):48–60.
   PubMedGoogle Scholar
• Kohne E, Grosse HP, Versmold H, et al. [HbM Erlangen: alpha2beta263(e7) tyr. New mutation with haemolysis and NADH-methaemoglobin reductase deficiency (author's transl)]. Z Kinderheilkd. 1975 Jul 1;120(1):69–78.
   PubMedGoogle Scholar
• Molchanova TP, Abaturov LV, Spivak VA, et al. [Hemoglobin M Saskatoon alpha 2 beta 2 63 (E7) His–Tyr. Structural identification, hemichrome formation and proteolytic degradation]. Mol Biol (Mosk). 1980 Nov–Dec;14(6):1253–1266.
   PubMed Web of Science ®Google Scholar
• Arbane-Dahmane M, Rouabhi F, Hocine M, et al. Hemoglobin M Saskatoon (alpha 2 beta 2 63(E7) His–>Tyr) in an Algerian family. Hemoglobin. 1985;9(5):509–511.
   PubMed Web of Science ®Google Scholar
• Kazanets EG, Andreeva AP, Khangulov SV, et al. [Hereditary cyanosis caused by the presence of abnormal hemoglobin M in the blood: its detection, identification and properties]. Gematol Transfuziol. 1990 Mar;35(3):9–13.
   PubMed Web of Science ®Google Scholar
• Waye JS, Patterson M, Eng B. De novo beta-globin gene mutation [beta 63(E7)His–>Tyr] giving rise to Hb M disease in a Newfoundlander. Hemoglobin. 1994 Nov;18(6):441–443.
   PubMed Web of Science ®Google Scholar
• Suryantoro P, Takeshima Y, Haryanto A, et al. C to T transition at the first nucleotide of codon 63 of the beta-globin gene corresponding to hemoglobin M-Saskatoon in an Indonesian boy. Jpn J Hum Genet. 1995 Jun;40(2):195–201.
   PubMedGoogle Scholar
• Kedar PS, Nadkarni AH, Phanasgoankar S, et al. Congenital methemoglobinemia caused by Hb-MRatnagiri (beta-63CAT–>TAT, His–>Tyr) in an Indian family. Am J Hematol. 2005 Jun;79(2):168–170.
   PubMed Web of Science ®Google Scholar
• Hutten M, Kohne E, Yagmur E, et al. Persistent cyanosis in a 4 month old infant with severe pneumonia and haemoglobin M. Klin Padiatr. 2009 Sep;221(5):305–307.
   PubMed Web of Science ®Google Scholar
• Brunner-Agten S, Hergersberg M, Herklotz R, et al. Compound heterozygosity of Hb Hamilton and de novo mutated HbM Saskatoon. Ann Hematol. 2010 May;89(5):517–518.
   PubMed Web of Science ®Google Scholar
• Akar N, Arslan C, Kurekci E. First observation of hemoglobin m Saskatoon (ss63 (e7) his > tyr(c-t)) in the iraqi population. Turk J Haematol. 2012 Sep;29(3):287–288.
   PubMed Web of Science ®Google Scholar
• Gupta O, Chhabra S, Kaur J, et al. Unusual C- and A2-window peaks (hemoglobin M-Saskatoon) in three north Indian patients. Indian J Hematol Blood Transfus. 2019 Jan;35(1):196–198.
   PubMed Web of Science ®Google Scholar
• Schiemsky T, Penders J, Kieffer D. Failing blood gas measurement due to methemoglobin forming hemoglobin variants: a case report and review of the literature. Acta Clin Belg. 2016 Jun;71(3):167–170.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Qiu L, Sun Y, et al. Optimal hemoglobin extinction coefficient data set for near-infrared spectroscopy. Biomed Opt Express. 2017 Nov 1;8(11):5151–5159.
   PubMed Web of Science ®Google Scholar
• Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf. 1996 Jun;14(6):394–405.
   PubMed Web of Science ®Google Scholar
• Swartzentruber GS, Yanta JH, Pizon AF. Methemoglobinemia as a complication of topical dapsone. N Engl J Med. 2015 Jan 29;372(5):491–492.
   PubMed Web of Science ®Google Scholar
• Katsube T, Sakamoto N, Kobayashi Y, et al. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency. Am J Hum Genet. 1991 Apr;48(4):799–808.
   PubMed Web of Science ®Google Scholar
• Shirabe K, Yubisui T, Borgese N, et al. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). J Biol Chem. 1992 Oct 5;267(28):20416–20421.
   PubMed Web of Science ®Google Scholar
• Percy MJ, McFerran NV, Lappin TR. Disorders of oxidised haemoglobin. Blood Rev.. 2005 Mar;19(2):61–68.
   PubMed Web of Science ®Google Scholar
• Murray L. Goldfrank’s toxicologic emergencies, 7th edition. Emerg Med Australas. 2004 Feb;16(1):87.
   PubMedGoogle Scholar
• Rehman A, Shehadeh M, Khirfan D, et al. Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man. BMJ Case Rep. 2018 Mar 28. doi:https://doi.org/10.1136/bcr-2017-223369.
   Google Scholar
• Goldstein GM, Doull J. Treatment of nitrite-induced methemoglobinemia with hyperbaric oxygen. Proc Soc Exp Biol Med. 1971 Oct;138(1):137–139.
   PubMed Web of Science ®Google Scholar
• Singh P, Rakesh K, Agarwal R, et al. Therapeutic whole blood exchange in the management of methaemoglobinemia: case series and systematic review of literature. Transfus Med. 2020 Jun;30(3):231–239.
   PubMed Web of Science ®Google Scholar